Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (1.286)
1
BI 655130 induction treatment in patients with moderate-tosevere ulcerative colitis : A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of BI 655130 Induction Therapy in patients with moderate-to-severely active ulcerative colitis who have failed previous biologics therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A Study of the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis : A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis - QUASAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
BI 655130 long-term treatment in patients with moderate-to-severe ulcerative colitis : An open label, long term safety trial of BI 655130 treatment in patients with moderate to severely active ulcerative colitis who have completed previous BI 655130 trials
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Study of efficacy, safety and tolerability of LYS006 in patients with mild to moderate ulcerative colitis : A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group study to assess the efficacy, safety and tolerability of LYS006 in patients with mild to moderate ulcerative colitis - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A follow-up study in patients with moderate to severe active ulcerative colitis. : A follow-up Phase IIa study to evaluate the long-term safety and efficacy profile of ABX464given at 50 mg once daily in subjects with Moderate to Severe Active Ulcerative Colitis. - Follow-up study in Moderate to Severe Active Ulcerative Colitis subjects.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
BI 655130 induction treatment in patients with moderate-to severe ulcerative colitis : A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of BI 655130 Induction Therapy in patients with moderate-to-severely active ulcerative colitis who have failed previous biologics therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
BI 655130 induction treatment in patients with moderate-tosevere ulcerative colitis : A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of BI 655130 Induction Therapy in patients with moderate-to-severely active ulcerative colitis who have failed previous biologics therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Study of the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis : A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis - QUASAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
BI 655130 long-term treatment in patients with moderate-to-severe ulcerative colitis : An open label, long term safety trial of BI 655130 treatment in patients with moderate to severely active ulcerative colitis who have completed previous BI 655130 trials
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[129]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
1.286
Aufsätze
1.286
E-Artikel
1.286
E-Ressourcen
Zeitschriftentitel
1.168
WHO International Clinical Trials Registry Plat...
118
ClinicalTrials.gov
Thema
1.286
610
Phase: Phase 2
1.286
Study Type: Interventional
749
Recruitment Status: Not yet recruiting
372
Recruitment Status: Authorised-recruitment may ...
120
Medical Condition: Ulcerative Colitis MedDRA ve...
116
Colitis, Ulcerative
111
Colitis
111
Ulcer
91
Medical Condition: Ulcerative Colitis
79
Recruitment Status: Completed
60
Medical Condition: Ulcerative Colitis MedDRA ve...
44
Medical Condition: Moderate to Severe Ulcerativ...
38
Medical Condition: Moderate-to-severely active ...
32
Medical Condition: Ulcerative Colitis MedDRA ve...
30
Medical Condition: Moderately to Severely Activ...
23
Recruitment Status: Terminated
20
Medical Condition: Moderate to Severe Active Ul...
20
Medical Condition: Moderately to Severely Activ...
20
Medical Condition: Ulcerative colitis MedDRA ve...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
819
2020-
461
2010-2019
6
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.280
Englisch
4
Latein
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...